← All institutions

Bernstein

218 reports

Reports from this institution

Bernstein

Bernstein: Lowe’s third-quarter same-store sales beat expectations; full-year revenue guidance raised, but margin outlook lowered

Lowe’s third-quarter same-store sales rose 1.8%, above the Bloomberg consensus estimate of 0.4%; however, gross margin declined year over year, and adjusted EPS beat expectations by less than the benefit from tariff refunds. The company raised its full-year sales and same-store sales guidance and lowered its margin target. Bernstein remains positive on the company’s relative valuation and the potential recovery in the housing market.

Bernstein

Bernstein: Raising Siemens FY27 growth forecast; automation and data-center demand are key

Bernstein raised its forecast for organic growth in Siemens’ FY27 industrial business from 8.4% under its previous model to 11.6%, above the consensus estimate of 11.1%. The automation recovery, margin improvement and data-center orders together support the upgrade; whether SI can achieve high growth depends on order conversion and project execution.

Bernstein

Bernstein: China’s power-equipment companies grew third-quarter revenue but not profits; the grid is steady, storage is growing fast, and solar is still bottoming out

Among the 40 Chinese power and electrical equipment companies tracked by Bernstein, third-quarter revenue rose 20.6% year on year, while net profit fell 21%. Almost all growth came from batteries and energy storage; grid orders and earnings proved relatively resilient, while storage faced margin pressure and solar remained some distance from a sustained recovery.

Bernstein

Bernstein: US Foods’ third-quarter profit slightly beat consensus, while sales and case volume came in below expectations

Growth in the independent restaurant business and improved profit per case supported US Foods’ third-quarter adjusted profit, but customer attrition and lower-than-expected food inflation weighed on sales and total case volume. Bernstein believes the gradual easing of these headwinds could improve growth in 2027, while near-term guidance still reflects pressure from macro conditions, fuel and sales expenses.

Bernstein

Bernstein: AI networking and communications equipment stocks fall 12%–42%; earnings upgrades still outweighed by valuation compression

Bernstein acknowledges its earlier short-term bullish call was wrong: covered stocks saw sharp pullbacks, even though results and guidance from five companies that have reported were above sell-side consensus. The firm remains positive on long-term demand, but believes financing, land and power concerns are weighing on valuations, and a full recovery will take longer.

Bernstein

Bernstein: Insulet’s third-quarter profit far exceeds expectations; the starting point for 2027 growth is lowered again

Insulet’s third-quarter revenue slightly beat expectations, while profit substantially exceeded forecasts, helped by factors including improved manufacturing efficiency; Bernstein believes intensifying competition and slower overseas growth will lower the starting point for growth in 2027, but remains positive on the company and raises its price target.

Bernstein

Bernstein: Zai Lab’s third-quarter revenue decline widens; recovery in 2027 depends on multiple products

Revenue in 3Q26 fell 7% year over year, with the decline widening from the second quarter; core products were weighed down by competition and price cuts, while lower R&D expenses helped narrow the loss. Bernstein is optimistic about a recovery in 2027 driven by some products and the pipeline, but the report’s written assessment of 2026 does not align with its revenue forecast table.

Bernstein

Bernstein: Can the U.S. biopharma rerating continue after Democrats take control of Congress?

Bernstein believes the policy noise around drug prices following Democrats’ wins in both chambers of Congress is not enough, in the near term, to overturn the investment case for pharmaceutical stocks: legislative hurdles and existing agreements provide a buffer, while defensive capital supports the rerating. But the sector’s forward P/E has climbed to 17.8x, while its historical post-election performance and the potential for a valuation pullback remain constraints.

Bernstein

Bernstein: Cloudflare third-quarter revenue grew 39%, firm sees growth potentially exceeding 40%

Cloudflare’s third-quarter revenue exceeded both the market consensus and Bernstein’s own forecast, with several growth drivers taking turns fueling optimism about further acceleration. However, monetization of the developer platform takes time to convert into revenue, and the GAAP operating loss widened; Bernstein nevertheless maintained its Market-Perform rating.